A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
Clinical trial NCT01157793 · COMPLETED
Trial details
- NCT number
- NCT01157793
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Primary completion
- 2005-02-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.